Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03472014 · ClinicalTrials.gov registry record · Phase 4
Special Access Program IMVAMUNE®
A Phase 4 study of Vaccination, sponsored by Bavarian Nordic.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03472014 is a Phase 4 study of Vaccination that has completed, run by Bavarian Nordic. The registered enrollment target is 22 participants, below the 10,232-participant average among 12 other Vaccination trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03472014, a Phase 4 study of Vaccination, has completed, sponsored by Bavarian Nordic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Prophylactic smallpox vaccination for personnel actively working with or in the vicinity of replicating vaccinia virus
Conditions Studied
Interventions
- BIOLOGICAL IMVAMUNE®
Study Locations (1)
California
- Palo Alto Medical Foundation - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-04-22 |
| Est. Completion | 2014-11-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03472014
The ClinicalTrials.gov registry entry for NCT03472014 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,232-participant average among 12 other Vaccination trials with a reported enrollment target (100% lower). The listed sponsor is Bavarian Nordic, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaccination appearing as the primary indexed condition, and to 1 intervention - of which IMVAMUNE® is the first listed.
NCT03472014 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03472014 about?
NCT03472014 is a clinical study titled "Special Access Program IMVAMUNE®". Prophylactic smallpox vaccination for personnel actively working with or in the vicinity of replicating vaccinia virus
What is the current status of trial NCT03472014?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2010-04-22. Estimated completion is 2014-11-14.
What conditions does trial NCT03472014 study?
This clinical trial studies the following conditions: Vaccination.
What interventions are being tested in trial NCT03472014?
The interventions under investigation include: IMVAMUNE® (BIOLOGICAL).
Who is sponsoring clinical trial NCT03472014?
This trial is sponsored by Bavarian Nordic, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03472014 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PFAS Exposure and Immune Response to Vaccination in Adults
COMPLETED · Phase 4
-
Can Stories Encourage the Elderly to Vaccinate? Combining Viewer-tailored Personal Narrative Videos With Informational Videos to Improve Vaccine Uptake Among Older Adults
RECRUITING · NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
RECRUITING · NA
-
ARISe at UMass Chan
RECRUITING · NA
-
Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
RECRUITING
-
Kaiser Colorado Flu Nudge
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.